Frontlight ResearchEarly access
Trial site
Tokyo Metropolitan Institute for Geriatrics and Gerontology
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Mild cognitive impairment2 trials
- Lewy body dementia1 trial
- Phase
- Phase 22 trials
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Biogen1 trial
- Eisai Inc.1 trial
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026